Patents by Inventor Sarah Parish

Sarah Parish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC METHODS
    Publication number: 20190071724
    Abstract: This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
    Type: Application
    Filed: April 30, 2018
    Publication date: March 7, 2019
    Inventors: Emma Link, Sarah Parish, Rory Collins, Mark Lathrop
  • Diagnostic methods
    Patent number: 9957563
    Abstract: This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: May 1, 2018
    Assignee: Isis Innovation Limited
    Inventors: Emma Link, Sarah Parish, Rory Collins, Mark Lathrop
  • DIAGNOSTIC METHODS
    Publication number: 20150079594
    Abstract: This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
    Type: Application
    Filed: November 20, 2014
    Publication date: March 19, 2015
    Inventors: Emma Link, Sarah Parish, Rory Collins, Mark Lathrop
  • Diagnostic methods
    Patent number: 8455194
    Abstract: This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: June 4, 2013
    Assignee: Isis Innovation Limited
    Inventors: Emma Link, Sarah Parish, Rory Collins, Mark Lathrop
  • DIAGNOSTIC METHODS
    Publication number: 20120202205
    Abstract: This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
    Type: Application
    Filed: February 29, 2012
    Publication date: August 9, 2012
    Inventors: Emma Link, Sarah Parish, Rory Collins, Mark Lathrop
  • DIAGNOSTIC METHODS
    Publication number: 20110112186
    Abstract: This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy.
    Type: Application
    Filed: February 27, 2009
    Publication date: May 12, 2011
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Emma Link, Sarah Parish, Rory Collins, Mark Lathrop